Coronavirus disease-2019 and heart: assessment of troponin and cardiovascular comorbidities as prognostic markers in patients hospitalized with coronavirus disease-2019 in a tertiary center in Brazil

Carregando...
Imagem de Miniatura
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
ASSOC MEDICA BRASILEIRA
Citação
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, v.69, n.7, article ID e20230350, 8p, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
OBJECTIVE: Our study aimed to evaluate the correlation of cardiac troponin T levels with comorbidities and in-hospital outcomes in patients with coronavirus disease-2019 in Brazil.METHODS: Data from a cohort of 3,596 patients who were admitted with suspected coronavirus disease-2019 in a Brazilian tertiary center, between March and August 2020, were reviewed. A total of 2,441 (68%) patients had cardiac troponin T determined in the first 72 h of admission and were stratified into two groups: elevated cardiac troponin T (cardiac troponin T >0.014 ng/mL) and normal cardiac troponin T. Associations between troponin, comorbidities, biomarkers, and outcomes were assessed. Regression models were built to assess the association of several variables with in-hospital mortality.RESULTS: A total of 2,441 patients were embraced, of which 924 (38%) had normal cardiac troponin T and 1,517 (62%) had elevated cardiac troponin T. Patients with elevated cardiac troponin T were older and had more comorbidities, such as cardiovascular disease, hypertension, diabetes, arrhythmia, renal dysfunction, liver disease, stroke, cancer, and dementia. Patients with abnormal cardiac troponin T also had more altered laboratory parameters on admission (i.e., leukocytes, C-reactive protein, D-dimer, and B-type natriuretic peptide), as well as more need for intensive care unit, vasoactive drugs, mechanical ventilation, dialysis, and blood transfusion. All-cause mortality was markedly higher among patients with increased cardiac troponin T (42 vs. 16%, P<0.001). Multiple regression analysis demonstrated that in-hospital mortality was not independently associated with troponin elevation.CONCLUSION: This study showed that cardiac troponin T elevation at admission was common and associated with several comorbidities, biomarkers, and clinical outcomes in patients hospitalized with coronavirus disease-2019, but it was not an independent marker of in-hospital mortality.
Palavras-chave
COVID-19, Troponin, Cardiovascular disease, Myocardial ischemia
Referências
  1. [Anonymous], COR BRAS
  2. Bastos ML, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2516
  3. Changal K, 2021, BMC CARDIOVASC DISOR, V21, DOI 10.1186/s12872-021-02450-3
  4. Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045
  5. Cunningham JW, 2021, CIRCULATION, V144, P177, DOI 10.1161/CIRCULATIONAHA.121.054969
  6. Guimaraes PO, 2021, IJC HEART VASC, V36, DOI 10.1016/j.ijcha.2021.100853
  7. Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017
  8. Han H, 2020, J MED VIROL, V92, P819, DOI 10.1002/jmv.25809
  9. Huang C, 2020, LANCET, V395, P496, DOI 10.1016/S0140-6736(20)30252-X
  10. Imazio M, 2020, HEART, V106, P1127, DOI 10.1136/heartjnl-2020-317186
  11. Iorio A, 2022, AM J CARDIOL, V167, P125, DOI 10.1016/j.amjcard.2021.11.054
  12. Lala A, 2020, J AM COLL CARDIOL, V76, P533, DOI [10.1016/j.jacc.2020.06.007, 10.1101/2020.04.20.20072702]
  13. Marcilio I, 2020, CLINICS, V75, DOI 10.6061/clinics/2020/e2166
  14. Metkus TS, 2021, CIRCULATION, V143, P553, DOI 10.1161/CIRCULATIONAHA.120.050543
  15. Nasir Kansestani Atefeh, 2021, J Tehran Heart Cent, V16, P1, DOI 10.18502/jthc.v16i1.6594
  16. Omland T, 2020, CIRCULATION, V142, P1878, DOI 10.1161/CIRCULATIONAHA.120.050089
  17. Polcwiartek Christoffer, 2022, Am Heart J Plus, V14, P100131, DOI 10.1016/j.ahjo.2022.100131
  18. Sandoval Y, 2020, J AM COLL CARDIOL, V76, P1244, DOI 10.1016/j.jacc.2020.06.068
  19. Shi SB, 2020, JAMA CARDIOL, V5, P802, DOI 10.1001/jamacardio.2020.0950
  20. Torres-Torres J, 2022, VIRUSES-BASEL, V14, DOI 10.3390/v14020271
  21. von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120
  22. Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3